Hypnotics and Sedatives: Clinical Trials

14 trials for Hypnotics and Sedatives, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

6 unknown, 3 completed, 3 recruiting, 1 enrolling by invitation. 5 Not applicable, 2 Phase 4, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Not applicable5Unknown 3, Enrolling by invitation 1, Recruiting 1
Phase 42Recruiting 1, Unknown 1
Phase 31Recruiting 1

Follow Hypnotics and Sedatives: new trials by email Literature Review of Hypnotics and Sedatives trials Research Report on Hypnotics and Sedatives

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Physical Activity Interventions for Sleep Improvement and Sedative-Hypnotic Reduction in Middle-Aged and Older Adults: Investigating the Role of Sarcopenia
resistance training, Relaxation training - Insomnia Chronic, Hypnotics and Sedatives
Not applicableEnrolling by invitationChang Gung Memorial Hospital402026-07-012026-10-27
Nebulized Ketamine for the Treatment of Major Depressive Disorder
nebulized ketamine, nebulized midazolam - Severe Depression, Moderate Depression
Phase 3RecruitingTheresa Jacob, PhD, MPH402024-10-162026-04-24
Comparison of Ciprofol-based and Propofol-based Total Intravenous Anesthesia on Postoperative Quality of Recovery
Ciprofol, Propofol - Anesthetics, Intravenous, Postoperative Complications
Not applicableUnknownXijing Hospital2802023-05-162024-04-09
Patient-centred Deprescribing of Psychotropic, Sedative and Anticholinergic Medication in Elderly Patients With Polypharmacy
PARTNER intervention, Control intervention - Deprescriptions, Antidepressive Agents
Not applicableRecruitingLudwig-Maximilians - University of Munich3522023-03-252025-05-04
Bispectral Index and Patient State Index During General Anesthesia With Remimazolam
Bispectral index and Patient state index monitoring - Remimazolam, Anesthesia, General
UnknownSeoul National University Hospital402022-07-012022-07-01
Dexmedetomidine for Analgosedation to Newborn Infants During Neonatal Intensive Care
dexmedetomidine - Intensive Care, Neonatal, Analgesia
WithdrawnRegion Skane2021-06-012024-07-01
Comparison Between Natural Sleep Endoscopy and Drug-induced Sleep Endoscopy in Patients With Obstructive Sleep Apnea
Drug-induced sleep endoscopy, Natural sleep endoscopy - Sleep Apnea, Obstructive, Sleep Apnea
Not applicableUnknownethisch.comite@uza.be402021-03-302021-07-26
Monitoring and Risk Prediction of Iatrogenic Sedative Hypnotics Addiction in a Shanghai Psychiatric Hospital
Hypnotics and Sedatives, Addiction
UnknownShanghai Mental Health Center1000002020-08-012020-08-07
Evaluation of Sedation in COVID-19 ARDS
Treatment group - Prone Position, Severe Acute Respiratory Syndrome Coronavirus 2
CompletedGoethe University1142020-03-012021-07-01
Cognitive Outcomes After Dexmedetomidine Sedation in Cardiac Surgery Patients
Dexmedetomidine Hydrochloride Group - Delirium, Cognitive Dysfunction
Phase 4RecruitingSunnybrook Health Sciences Centre24002019-12-012025-12-01
Acceptable Hemodynamic Changes in Dexmedetomidine for Single Intravenous Bolus Injection
Dexmedetomidine - Delirium, Postoperative Complications
Phase 4UnknownSecond Affiliated Hospital of Wenzhou Medical University422018-05-232019-09-25
Clonidine for Analgesia to Preterm Infants During Neonatal Intensive Care
Clonidine - Intensive Care, Neonatal, Analgesia
CompletedRegion Skane402018-04-062023-08-04
Generalized Versus Personalized Music Therapy in the ICU to Reduce Sedation
Generalized Music therapy, Personalized Music therapy - Critical Illness, Hypnotics and Sedatives
Not applicableUnknownUniversity of Milan1532017-05-012018-06-26
Longitudinal Analysis of Drug Burden Index
Polypharmacy, Anticholinergics
CompletedUniversity of Groningen99852016-06-012017-01-19

Narrower conditions

Agnosia (2)  ·  Delirium (2)  ·  Mental Disorders (2)  ·  Nervous System Diseases (2)  ·  Neurocognitive Disorders (2)  ·  Postoperative Complications (2)  ·  Apnea (1)  ·  Behavior, Addictive (1)  ·  Breast Diseases (1)  ·  Cognition Disorders (1)  ·  Cognitive Dysfunction (1)  ·  Confusion (1)  ·  Critical Illness (1)  ·  Depression (1)  ·  Dyssomnias (1)

Broader conditions

Pathological Conditions, Signs and Symptoms (8)  ·  Neurologic Manifestations (5)  ·  Signs and Symptoms (5)  ·  Nervous System Diseases (4)  ·  Behavior (3)  ·  Neurobehavioral Manifestations (3)  ·  Mental Disorders (2)  ·  Pathologic Processes (2)  ·  Perceptual Disorders (2)  ·  Atrophy (1)  ·  Behavioral Symptoms (1)  ·  Compulsive Behavior (1)  ·  Confusion (1)  ·  Disease Attributes (1)  ·  Dyssomnias (1)

Interventions

Dexmedetomidine (3)  ·  (2-(1R)-1-cyclopropyl)ethyl-6-isopropyl-phenol (1)  ·  Clonidine (1)  ·  HSK3486 (1)  ·  Ketamine (1)  ·  Midazolam (1)  ·  Propofol (1)  ·  Relaxation Therapy (1)  ·  Resistance Training (1)

Sponsors

Region Skane (2)  ·  Chang Gung Memorial Hospital (1)  ·  Goethe University (1)  ·  Ludwig-Maximilians - University of Munich (1)  ·  Second Affiliated Hospital of Wenzhou Medical University (1)  ·  Seoul National University Hospital (1)  ·  Shanghai Mental Health Center (1)  ·  Sunnybrook Health Sciences Centre (1)  ·  Theresa Jacob, PhD, MPH (1)  ·  University of Groningen (1)  ·  University of Milan (1)  ·  Xijing Hospital (1)  ·  ethisch.comite@uza.be (1)

Countries

China (2)  ·  Germany (2)  ·  Sweden (2)  ·  Belgium (1)  ·  Canada (1)  ·  Italy (1)  ·  South Korea (1)  ·  Taiwan (1)  ·  United States (1)

Top investigators

Elisabeth Norman, MD (2)  ·  Armin N Flinspach, MD (1)  ·  Haopeng Zhang (1)  ·  Hee-Soo Kim, MD,PhD (1)  ·  Jun Li (1)  ·  Olivier Vanderveken, MD, PhD (1)  ·  Stephen Choi, MD,MSc,FRCPC (1)  ·  Theresa Jacob, PhD, MPH (1)  ·  Tobias Dreischulte, Prof. Dr. (1)

Results publications

PMID 33849856, PMID 34950101, PMID 38867317, PMID 41522713

NIH funding

2015 (1), 2017 (1)